The University of Chicago Header Logo

Kenneth Gordon

Concepts (454)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Psoriasis
151
2024
239
33.220
Why?
Dermatologic Agents
37
2022
71
8.870
Why?
Antibodies, Monoclonal
53
2021
1379
7.710
Why?
Antibodies, Monoclonal, Humanized
67
2024
931
7.640
Why?
Interleukin-23
18
2023
54
4.600
Why?
Biological Products
14
2023
143
3.920
Why?
Severity of Illness Index
75
2024
1776
3.870
Why?
Arthritis, Psoriatic
17
2023
32
3.750
Why?
Adalimumab
25
2020
80
3.670
Why?
Ustekinumab
18
2021
47
3.010
Why?
Double-Blind Method
56
2024
1696
2.880
Why?
Treatment Outcome
81
2024
7831
2.830
Why?
Interleukin-17
8
2019
101
2.260
Why?
Quality of Life
27
2023
1581
2.260
Why?
Th17 Cells
3
2024
81
1.890
Why?
Interleukin-12
13
2023
109
1.830
Why?
Skin Diseases
7
2020
165
1.570
Why?
Humans
172
2024
85796
1.530
Why?
Immunologic Factors
9
2014
170
1.490
Why?
Adult
86
2024
25522
1.450
Why?
Middle Aged
85
2024
24742
1.340
Why?
Tumor Necrosis Factor-alpha
18
2020
686
1.300
Why?
Immunoglobulin G
14
2018
457
1.210
Why?
Male
95
2024
40654
1.210
Why?
Recombinant Fusion Proteins
9
2008
560
1.180
Why?
Female
95
2023
44218
1.120
Why?
Patient Reported Outcome Measures
5
2020
164
1.100
Why?
Receptors, Tumor Necrosis Factor
13
2011
89
1.090
Why?
Interleukin-23 Subunit p19
3
2019
7
1.060
Why?
Methotrexate
9
2023
249
1.060
Why?
Piperidines
4
2020
160
1.010
Why?
Pyrroles
3
2019
183
0.970
Why?
Withholding Treatment
4
2019
112
0.960
Why?
Anti-Inflammatory Agents
6
2019
338
0.960
Why?
Arthritis, Rheumatoid
5
2019
164
0.950
Why?
Pyrimidines
4
2020
367
0.910
Why?
Chronic Disease
15
2023
930
0.880
Why?
Drug Administration Schedule
17
2021
898
0.860
Why?
Anti-Inflammatory Agents, Non-Steroidal
5
2022
237
0.840
Why?
Anxiety
3
2020
286
0.790
Why?
Skin Neoplasms
11
2020
546
0.780
Why?
Immunosuppressive Agents
10
2019
977
0.780
Why?
Hidradenitis Suppurativa
2
2019
11
0.770
Why?
Liver Diseases
5
2020
240
0.750
Why?
Depression
6
2020
472
0.750
Why?
Clinical Trials as Topic
5
2021
1121
0.740
Why?
Dose-Response Relationship, Drug
17
2018
1928
0.720
Why?
Uveitis
2
2019
29
0.710
Why?
Interleukins
1
2019
134
0.650
Why?
Etanercept
15
2019
32
0.650
Why?
Thalidomide
4
2024
54
0.630
Why?
Randomized Controlled Trials as Topic
12
2022
812
0.610
Why?
Immunotherapy
5
2023
631
0.600
Why?
Biological Therapy
4
2020
46
0.600
Why?
TYK2 Kinase
3
2022
7
0.590
Why?
Maintenance Chemotherapy
4
2020
76
0.550
Why?
Placebos
9
2019
212
0.530
Why?
T-Lymphocytes
10
2007
1200
0.530
Why?
Aged
36
2023
18161
0.510
Why?
Crohn Disease
3
2019
731
0.470
Why?
Drug-Related Side Effects and Adverse Reactions
4
2011
197
0.470
Why?
Candidiasis, Oral
2
2024
4
0.460
Why?
Antibodies, Blocking
1
2013
21
0.460
Why?
Phototherapy
5
2019
35
0.450
Why?
Colitis, Ulcerative
2
2019
711
0.440
Why?
Bowen's Disease
3
1997
9
0.420
Why?
Cross-Over Studies
5
2020
391
0.420
Why?
Dermatology
4
2020
35
0.390
Why?
Time Factors
13
2018
5178
0.380
Why?
Heterocyclic Compounds
2
2021
17
0.370
Why?
Injections, Subcutaneous
9
2021
116
0.370
Why?
Adolescent
16
2023
8959
0.370
Why?
Keratolytic Agents
3
2008
4
0.360
Why?
Aged, 80 and over
11
2020
6479
0.360
Why?
Protein Kinase Inhibitors
2
2014
590
0.360
Why?
Adrenal Cortex Hormones
4
2019
261
0.350
Why?
Retreatment
4
2017
107
0.350
Why?
PUVA Therapy
4
2009
24
0.340
Why?
Pruritus
6
2020
26
0.340
Why?
Follow-Up Studies
11
2019
3591
0.330
Why?
Drug Substitution
2
2018
23
0.310
Why?
Risk Assessment
9
2018
2213
0.300
Why?
Recurrence
3
2019
1136
0.300
Why?
Young Adult
11
2023
5961
0.290
Why?
Cardiovascular Diseases
8
2019
668
0.280
Why?
Patient Education as Topic
3
2020
342
0.270
Why?
Langerhans Cells
1
2005
13
0.270
Why?
Epidermis
2
2005
101
0.270
Why?
Cyclosporine
6
2020
235
0.270
Why?
Drug Eruptions
2
1996
33
0.260
Why?
Prognosis
5
2018
3639
0.260
Why?
Autoimmune Diseases
2
1998
241
0.260
Why?
Inflammatory Bowel Diseases
5
2024
548
0.250
Why?
Carcinoma, Basal Cell
4
2012
54
0.250
Why?
Patient Advocacy
1
2005
49
0.250
Why?
Delphi Technique
2
2018
80
0.250
Why?
Carcinoma, Squamous Cell
5
2012
1076
0.250
Why?
Metabolic Syndrome
4
2019
126
0.250
Why?
Autoantibodies
2
2003
267
0.250
Why?
Graft vs Host Disease
1
2007
365
0.240
Why?
Health Care Costs
2
2016
232
0.240
Why?
Laser Therapy
2
1996
142
0.240
Why?
Certolizumab Pegol
2
2020
19
0.230
Why?
Biomarkers
3
2021
1697
0.230
Why?
Practice Guidelines as Topic
4
2019
992
0.230
Why?
Clinical Trials, Phase III as Topic
6
2024
170
0.230
Why?
Skin
7
2023
554
0.230
Why?
Hand Dermatoses
2
2020
9
0.230
Why?
Terminology as Topic
1
2005
215
0.230
Why?
Erythema
2
2020
27
0.220
Why?
Incidence
4
2018
1543
0.220
Why?
Dermatitis, Atopic
1
2023
52
0.220
Why?
ROC Curve
2
2016
752
0.220
Why?
Patients
1
2023
100
0.210
Why?
Arthralgia
2
2019
36
0.210
Why?
Macrolides
1
2001
31
0.210
Why?
Syringes
1
2021
13
0.200
Why?
Liver Cirrhosis
2
2020
300
0.200
Why?
Jaundice
2
2020
14
0.200
Why?
Consensus
2
2023
330
0.200
Why?
Sunscreening Agents
1
2001
7
0.200
Why?
Mental Health
2
2019
162
0.190
Why?
Administration, Oral
3
2018
674
0.190
Why?
Photochemotherapy
2
2019
97
0.190
Why?
CD4-Positive T-Lymphocytes
1
2003
427
0.190
Why?
Xanthomatosis
1
2020
5
0.190
Why?
Hemochromatosis
1
2020
11
0.190
Why?
Cohort Studies
3
2023
2738
0.190
Why?
Anticarcinogenic Agents
1
2001
70
0.190
Why?
Respiratory Tract Infections
2
2019
105
0.180
Why?
Liver Cirrhosis, Biliary
1
2020
29
0.180
Why?
Psychometrics
2
2020
327
0.180
Why?
Tacrolimus
1
2001
373
0.180
Why?
Hepatitis B, Chronic
1
2020
32
0.180
Why?
Evidence-Based Medicine
6
2020
415
0.180
Why?
Obesity
5
2019
943
0.180
Why?
Hemangioma
1
2020
60
0.180
Why?
Electronic Health Records
1
2023
320
0.180
Why?
Infliximab
6
2019
151
0.180
Why?
Multivariate Analysis
3
2018
985
0.180
Why?
Antirheumatic Agents
2
2012
54
0.180
Why?
Complementary Therapies
1
2020
54
0.180
Why?
Foundations
4
2020
15
0.180
Why?
United States
10
2020
6582
0.170
Why?
CD11 Antigens
5
2006
14
0.170
Why?
Headache
1
2019
72
0.170
Why?
Epitopes
3
1998
255
0.170
Why?
Hepatitis C, Chronic
1
2020
126
0.170
Why?
Remission Induction
4
2020
722
0.160
Why?
Digestive System Diseases
1
1998
18
0.160
Why?
Janus Kinase Inhibitors
1
2018
19
0.160
Why?
Body Surface Area
1
2018
36
0.160
Why?
Social Class
1
2018
128
0.160
Why?
Fingers
2
1996
68
0.150
Why?
Disease Progression
3
2013
1458
0.150
Why?
Epidermolysis Bullosa Acquisita
1
1997
2
0.150
Why?
Photopheresis
1
1997
12
0.150
Why?
Fractures, Spontaneous
1
2017
11
0.150
Why?
Linear Models
1
2018
420
0.150
Why?
Physician's Role
1
2019
175
0.150
Why?
Patient Preference
1
2018
104
0.150
Why?
Multicenter Studies as Topic
3
2006
149
0.150
Why?
Neoplasms, Multiple Primary
1
1997
100
0.140
Why?
Absenteeism
1
2016
9
0.140
Why?
Pain
2
2018
387
0.140
Why?
Inpatients
2
2016
298
0.140
Why?
Clonazepam
1
1996
3
0.140
Why?
Lymphocyte Activation
5
2003
733
0.140
Why?
Neuropsychological Tests
1
2018
502
0.140
Why?
GABA Modulators
1
1996
9
0.140
Why?
Efficiency
1
2016
38
0.140
Why?
Antidepressive Agents, Second-Generation
1
1996
19
0.140
Why?
Drug Therapy, Combination
4
2019
787
0.140
Why?
Mycosis Fungoides
1
1996
23
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
1997
2438
0.140
Why?
Combined Modality Therapy
5
2020
1677
0.140
Why?
Receptors, Interleukin-17
1
2015
10
0.140
Why?
Fluoxetine
1
1996
42
0.130
Why?
Phosphodiesterase 4 Inhibitors
1
2015
3
0.130
Why?
Osteoporosis
1
2017
120
0.130
Why?
Sarcoma, Kaposi
1
1995
19
0.130
Why?
Administration, Cutaneous
3
2020
58
0.130
Why?
Astrocytes
3
2002
139
0.120
Why?
Patient Satisfaction
3
2014
454
0.120
Why?
Doxorubicin
1
1995
295
0.120
Why?
Acitretin
3
2020
4
0.120
Why?
Coronary Artery Disease
2
2008
337
0.120
Why?
Models, Statistical
1
2017
574
0.120
Why?
Hospitalization
2
2016
830
0.120
Why?
Retrospective Studies
4
2023
8466
0.120
Why?
Sickness Impact Profile
1
2013
27
0.120
Why?
Patient Outcome Assessment
1
2014
84
0.110
Why?
Hospital Mortality
3
2016
350
0.110
Why?
Disability Evaluation
1
2013
136
0.110
Why?
Child
6
2023
6930
0.110
Why?
Wound Healing
2
2006
345
0.110
Why?
Rheumatic Diseases
1
2012
20
0.100
Why?
Adverse Drug Reaction Reporting Systems
1
2011
22
0.100
Why?
Inflammation
2
2008
923
0.100
Why?
Cross-Sectional Studies
4
2018
1604
0.100
Why?
Healthcare Disparities
1
2016
372
0.100
Why?
Acute Disease
2
2023
827
0.100
Why?
Safety Management
1
2011
56
0.100
Why?
Long-Term Care
1
2011
61
0.100
Why?
SEER Program
1
2011
190
0.100
Why?
Global Health
2
2012
177
0.090
Why?
Keratinocytes
2
2009
144
0.090
Why?
Academies and Institutes
2
2020
31
0.090
Why?
Opportunistic Infections
3
2018
59
0.090
Why?
Health Status Indicators
2
2007
104
0.090
Why?
Drug Approval
1
2009
62
0.080
Why?
Depressive Disorder
1
2010
217
0.080
Why?
United States Food and Drug Administration
1
2009
126
0.080
Why?
Comorbidity
3
2019
912
0.080
Why?
Cytokines
2
2003
781
0.080
Why?
Placebo Effect
1
2008
29
0.080
Why?
Myocardial Infarction
1
2011
354
0.080
Why?
Logistic Models
2
2016
1179
0.080
Why?
Dyslipidemias
2
2019
105
0.080
Why?
B7-1 Antigen
2
1998
75
0.080
Why?
CD2 Antigens
1
2007
22
0.070
Why?
Computer Graphics
2
2003
100
0.070
Why?
Immune System
1
2007
93
0.070
Why?
Etretinate
1
2006
4
0.070
Why?
Population Surveillance
1
2007
214
0.070
Why?
Syndrome
2
1998
445
0.070
Why?
Bone Marrow Transplantation
1
2007
286
0.070
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2007
136
0.070
Why?
Animals
7
2013
26652
0.070
Why?
Candidiasis
2
2016
36
0.070
Why?
Vaccination
1
2007
256
0.070
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2007
173
0.070
Why?
Disease Models, Animal
2
2005
2241
0.070
Why?
Stevens-Johnson Syndrome
1
2005
22
0.070
Why?
Cell Count
1
2005
197
0.070
Why?
Biopsy
2
2007
1163
0.070
Why?
Registries
2
2020
702
0.070
Why?
Neoplasms
4
2019
2895
0.070
Why?
Surveys and Questionnaires
4
2016
2500
0.070
Why?
Prospective Studies
4
2018
4160
0.060
Why?
Neutropenia
2
2016
215
0.060
Why?
Mice, SCID
1
2005
254
0.060
Why?
Fatigue
1
2006
174
0.060
Why?
Skin Transplantation
1
2005
172
0.060
Why?
Lymphoma, Non-Hodgkin
1
2007
261
0.060
Why?
Transplantation, Heterologous
1
2005
363
0.060
Why?
Patient Selection
1
2008
676
0.060
Why?
Interferon-gamma
4
2002
445
0.060
Why?
Nova Scotia
1
2003
2
0.060
Why?
Bacteriophage phi X 174
1
2003
2
0.060
Why?
Antigen-Antibody Reactions
1
2003
23
0.060
Why?
Tetanus Toxoid
1
2003
10
0.060
Why?
Injections, Intramuscular
1
2003
63
0.060
Why?
Antigen-Presenting Cells
2
2002
139
0.060
Why?
Lymphocyte Count
1
2003
94
0.060
Why?
Life Style
2
2019
171
0.060
Why?
Eye Diseases
2
2002
53
0.060
Why?
Skin, Artificial
1
2002
8
0.060
Why?
Drug Delivery Systems
1
2004
178
0.060
Why?
Drug Design
1
2003
124
0.060
Why?
Length of Stay
2
2016
704
0.060
Why?
Self Report
2
2015
288
0.050
Why?
Recombinant Proteins
2
2002
1018
0.050
Why?
Insurance, Health
1
2023
156
0.050
Why?
Forecasting
1
2003
301
0.050
Why?
Stroke
1
2011
943
0.050
Why?
Illinois
1
2003
462
0.050
Why?
Risk Factors
4
2008
5251
0.050
Why?
Infant, Newborn
2
2019
2381
0.050
Why?
Pancytopenia
1
2002
23
0.050
Why?
Spondylitis, Ankylosing
2
2012
24
0.050
Why?
Vitamin D
2
2018
260
0.050
Why?
Arthritis, Juvenile
2
2012
32
0.050
Why?
Drug Combinations
1
2002
200
0.050
Why?
Infant
2
2019
3051
0.050
Why?
Lymphoproliferative Disorders
1
2002
107
0.050
Why?
Collagen
1
2002
273
0.050
Why?
Adjuvants, Immunologic
1
2002
167
0.050
Why?
California
2
2015
137
0.050
Why?
Child, Preschool
2
2019
3612
0.050
Why?
Sunlight
1
2001
26
0.050
Why?
Interferon Type I
1
2021
175
0.050
Why?
Pemphigus, Benign Familial
1
2000
1
0.050
Why?
Controlled Clinical Trials as Topic
2
2011
22
0.050
Why?
Nausea
1
2002
175
0.050
Why?
Health Knowledge, Attitudes, Practice
1
2005
500
0.050
Why?
Databases, Factual
2
2016
813
0.050
Why?
Pneumonia
1
2002
179
0.050
Why?
Anthralin
1
2019
1
0.050
Why?
Coal Tar
1
2019
1
0.050
Why?
Nicotinic Acids
1
2019
8
0.050
Why?
Retinoids
1
2019
17
0.050
Why?
Endothelium, Vascular
1
2002
430
0.040
Why?
Demography
1
2020
177
0.040
Why?
Botulinum Toxins, Type A
1
2000
49
0.040
Why?
Hemangioendothelioma
1
1999
9
0.040
Why?
Antigens, CD
2
2002
459
0.040
Why?
Calcineurin Inhibitors
1
2019
55
0.040
Why?
Meta-Analysis as Topic
1
2019
85
0.040
Why?
Lymphoma
2
2008
262
0.040
Why?
Drug Monitoring
1
2020
117
0.040
Why?
Lung Diseases, Obstructive
1
2019
19
0.040
Why?
Cost of Illness
1
2020
147
0.040
Why?
Biosimilar Pharmaceuticals
1
2019
20
0.040
Why?
Mice
5
2005
11439
0.040
Why?
Foot Dermatoses
1
2018
3
0.040
Why?
Nails
1
2018
7
0.040
Why?
Scalp Dermatoses
1
2018
10
0.040
Why?
Pancreatic Diseases
1
1998
51
0.040
Why?
Canada
2
2010
200
0.040
Why?
Cell Transformation, Neoplastic
1
2001
428
0.040
Why?
Income
1
2018
76
0.040
Why?
Encephalomyelitis, Autoimmune, Experimental
1
1998
57
0.040
Why?
Sleep Apnea Syndromes
1
2019
103
0.040
Why?
Myelin Sheath
1
1998
84
0.040
Why?
Apoptosis
2
2007
1690
0.040
Why?
Educational Status
1
2018
190
0.040
Why?
Isotretinoin
1
1997
23
0.040
Why?
Insulin Resistance
1
2019
359
0.040
Why?
Fluorescent Antibody Technique, Indirect
1
1997
69
0.040
Why?
Genetic Therapy
1
1999
343
0.040
Why?
Overweight
1
2018
116
0.040
Why?
Antigen Presentation
1
1998
210
0.040
Why?
Basement Membrane
1
1997
54
0.040
Why?
Ovalbumin
1
1997
109
0.040
Why?
Presenteeism
1
2016
1
0.040
Why?
Interferon-alpha
1
1997
234
0.040
Why?
Analysis of Variance
2
2010
901
0.040
Why?
Health Surveys
1
2017
236
0.040
Why?
Medication Adherence
1
2018
123
0.040
Why?
Intention to Treat Analysis
1
2016
69
0.040
Why?
Immunoconjugates
1
1997
106
0.030
Why?
Kidney Diseases
1
2019
316
0.030
Why?
Sex Distribution
1
2016
170
0.030
Why?
Age Distribution
1
2016
200
0.030
Why?
Georgia
1
2015
34
0.030
Why?
Colorado
1
2015
35
0.030
Why?
Washington
1
2015
48
0.030
Why?
Insurance Coverage
1
2016
117
0.030
Why?
Foot
1
1995
50
0.030
Why?
Liposomes
1
1995
92
0.030
Why?
Gastrointestinal Diseases
1
1996
145
0.030
Why?
Janus Kinase 3
1
2014
9
0.030
Why?
Acquired Immunodeficiency Syndrome
1
1995
78
0.030
Why?
Single-Blind Method
2
2006
148
0.030
Why?
Drug Carriers
1
1995
82
0.030
Why?
Membrane Glycoproteins
1
1997
429
0.030
Why?
Hepatitis, Viral, Human
2
2009
25
0.030
Why?
Infusions, Intravenous
1
1995
429
0.030
Why?
Qualitative Research
1
2015
256
0.030
Why?
Odds Ratio
1
2016
676
0.030
Why?
Hand
1
1995
129
0.030
Why?
Drug Resistance
1
2014
232
0.030
Why?
Socioeconomic Factors
1
2016
561
0.030
Why?
Carbon Dioxide
1
1994
188
0.030
Why?
Eye Neoplasms
1
1993
27
0.030
Why?
Macrophages
2
2007
560
0.030
Why?
Body Mass Index
2
2008
755
0.030
Why?
Patient Participation
1
2015
215
0.030
Why?
Hypertension
1
2019
703
0.030
Why?
Skin Diseases, Infectious
1
2012
13
0.030
Why?
Focus Groups
1
2013
155
0.030
Why?
Survival Analysis
1
2016
1532
0.030
Why?
Patient Dropouts
1
2012
28
0.030
Why?
Brain
1
2002
2219
0.030
Why?
Diagnosis, Differential
1
1996
1561
0.030
Why?
Case Management
1
2011
24
0.020
Why?
Health Status
1
2013
360
0.020
Why?
Reproducibility of Results
1
2017
2702
0.020
Why?
Cognition
1
2015
570
0.020
Why?
Neoplasm Recurrence, Local
1
1996
1313
0.020
Why?
Risk
1
2011
657
0.020
Why?
Maximum Tolerated Dose
1
2010
269
0.020
Why?
Diabetes Mellitus, Type 2
1
2018
1137
0.020
Why?
Histocompatibility Antigens Class II
2
2002
159
0.020
Why?
Administration, Topical
1
2009
95
0.020
Why?
Ultraviolet Therapy
1
2008
15
0.020
Why?
Reference Values
1
2010
663
0.020
Why?
Prevalence
1
2012
1210
0.020
Why?
Survival Rate
2
2005
1849
0.020
Why?
Nasopharyngitis
1
2008
2
0.020
Why?
Tuberculin Test
1
2007
5
0.020
Why?
Hematologic Tests
1
2007
14
0.020
Why?
Liver Function Tests
1
2007
93
0.020
Why?
Brain Neoplasms
1
1993
763
0.020
Why?
Sweden
1
2007
40
0.020
Why?
Antibodies, Antinuclear
1
2007
82
0.020
Why?
C-Reactive Protein
1
2008
187
0.020
Why?
Medical Records
1
2007
119
0.020
Why?
Immunophenotyping
1
2007
211
0.020
Why?
International Cooperation
1
2007
124
0.020
Why?
Physical Examination
1
2007
148
0.020
Why?
Patient Compliance
1
2008
220
0.020
Why?
Pregnancy Complications
1
2009
337
0.020
Why?
Ontario
1
2006
52
0.020
Why?
Fibrosis
1
2006
201
0.020
Why?
Burn Units
1
2005
21
0.020
Why?
Cells, Cultured
2
2002
2836
0.020
Why?
Self-Assessment
1
2005
46
0.020
Why?
Hospitals, University
1
2005
194
0.020
Why?
Biopsy, Needle
1
2005
234
0.020
Why?
Transforming Growth Factor beta
1
2006
302
0.020
Why?
Buttocks
1
2003
10
0.010
Why?
Smoking
1
2008
604
0.010
Why?
Scrotum
1
2003
17
0.010
Why?
Dendritic Cells
1
2007
427
0.010
Why?
Data Interpretation, Statistical
1
2005
297
0.010
Why?
Thigh
1
2003
38
0.010
Why?
Statistics, Nonparametric
1
2003
306
0.010
Why?
Biomedical Engineering
1
2002
20
0.010
Why?
Biomedical Research
1
2007
374
0.010
Why?
Mohs Surgery
1
2002
21
0.010
Why?
Myelin Proteolipid Protein
1
2002
2
0.010
Why?
Hybridomas
1
2002
75
0.010
Why?
Pregnancy
1
2009
2899
0.010
Why?
Clone Cells
1
2002
213
0.010
Why?
Coculture Techniques
1
2002
164
0.010
Why?
Interleukin-2
1
2002
250
0.010
Why?
Cell Adhesion Molecules
1
2002
163
0.010
Why?
T-Lymphocytes, Helper-Inducer
1
2002
132
0.010
Why?
Pain Measurement
1
2002
321
0.010
Why?
Cell Differentiation
1
2007
1471
0.010
Why?
Immunohistochemistry
1
2005
1760
0.010
Why?
HIV Infections
1
2009
774
0.010
Why?
Sweat Glands
1
2000
6
0.010
Why?
Pain, Postoperative
1
2002
240
0.010
Why?
Peptide Fragments
1
2002
459
0.010
Why?
Injections
1
2000
108
0.010
Why?
Axilla
1
2000
99
0.010
Why?
Mice, Inbred Strains
1
1999
307
0.010
Why?
Drug Synergism
1
1999
302
0.010
Why?
Neoplasm Transplantation
1
1999
393
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1999
378
0.010
Why?
Adoptive Transfer
1
1998
169
0.010
Why?
Cell Division
1
1999
693
0.010
Why?
Cell Line
1
2002
2474
0.010
Why?
Tumor Cells, Cultured
1
1999
1041
0.010
Why?
Mice, Nude
1
1999
791
0.010
Why?
B7-2 Antigen
1
1997
40
0.010
Why?
Abatacept
1
1997
84
0.010
Why?
Nail Diseases
1
1996
5
0.010
Why?
Peutz-Jeghers Syndrome
1
1996
8
0.010
Why?
CTLA-4 Antigen
1
1997
135
0.010
Why?
Antigens, Differentiation
1
1997
141
0.010
Why?
Adenomatous Polyposis Coli
1
1996
39
0.010
Why?
Gastrointestinal Neoplasms
1
1996
106
0.010
Why?
Nerve Tissue Proteins
1
1998
504
0.010
Why?
Gene Expression
1
1999
1286
0.010
Why?
Mice, Inbred BALB C
1
1997
1060
0.010
Why?
Gastrointestinal Hemorrhage
1
1996
230
0.010
Why?
Vitreous Body
1
1993
54
0.010
Why?
Amino Acid Sequence
1
1997
2065
0.010
Why?
Molecular Sequence Data
1
1997
3034
0.010
Why?
RNA, Messenger
1
1997
1987
0.010
Why?
Gordon's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (454)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_